In HCC, infiltrating T cells are functionally inhibited by multiple immune suppression mechanisms, such as the PD-1 pathway that diminishes antitumor immunity, impairing T cell proliferation and cytotoxicity, and IFN-γ production and release in the TME. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.